Butyronex 20mg Injection
PDF Leaflet Revision Date: 11 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastrointestinal spasm.
Dosage (summary)
20 mg IM/IV for adults and children >12 years, repeat after 30 mins if needed.
Special Populations
- Elderly
- Children
Pregnancy & Breastfeeding
Not recommended during pregnancy and breastfeeding due to insufficient safety data.
Key Drug Interactions
- Anticholinergics
- Beta-adrenergic medicines
- Dopamine antagonists
- Alcohol
Contraindications
- Hypersensitivity
- Porphyria
- Prostatic enlargement
- Paralytic ileus
- Pyloric stenosis
- Fever
- Megacolon
- Tachycardia
- Ulcerative colitis
- Glaucoma
- Myasthenia gravis
- Pregnancy
- Breastfeeding
Common side effects
- Tachycardia
- Dry mouth
- Constipation
- Dizziness
- Accommodation disorder
Counselling Points
- Avoid driving if experiencing dizziness
- Report any severe side effects
- Use caution in hot weather due to reduced sweating
Serious warnings
- Anaphylaxis
- Caution in cardiac conditions
- Monitor for severe abdominal pain
Important Disclaimer
The Butyronex 20mg Injection professional information leaflet below is the property of Lebasi Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
